Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis. | Noncoding RNA Res | 2023 | 36311994 | PubTator, text mining | PubMed |
| Role of Long Intergenic Noncoding RNAs in Cancers with an Overview of MicroRNA Binding. | Mol Diagn Ther | 2023 | 36287372 | PubTator, text mining | PubMed |
| Circulating LncRNAs landscape as potential biomarkers in breast cancer. | Cancer Rep (Hoboken) | 2023 | 36274054 | PubTator, text mining | PubMed |
| Molecular hallmarks of long non-coding RNAs in aging and its significant effect on aging-associated diseases. | Neural Regen Res | 2023 | 36254975 | PubTator, text mining | PubMed |
| Evaluation of the Regulatory Role of Circadian Rhythm Related Long Non-Coding RNAs in ADHD Etiogenesis. | J Atten Disord | 2023 | 36254757 | PubTator, text mining | PubMed |
| N-nitrosamines-mediated downregulation of LncRNA-UCA1 induces carcinogenesis of esophageal squamous by regulating the alternative splicing of FGFR2. | Sci Total Environ | 2023 | 36169023 | PubTator, text mining | PubMed |
| Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis. | Cancer Med | 2023 | 36057947 | PubTator, text mining | PubMed |
| LncRNA-UCA1 regulates lung adenocarcinoma progression through competitive binding to miR-383. | Cell Cycle | 2023 | 35980157 | PubTator, text mining | PubMed |
| Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling. | J Adv Res | 2023 | 35973552 | PubTator, text mining | PubMed |
| Long Non-coding RNA UCA1a Promotes Proliferation via PKM2 in Cervical Cancer. | Reprod Sci | 2023 | 35927414 | PubTator, text mining | PubMed |
| MicroRNA-204-5p: A pivotal tumor suppressor. | Cancer Med | 2023 | 35908280 | PubTator, text mining | PubMed |
| Plasma Lnc-UCA1/miR-138 axis as a potential biomarker for gestational diabetes mellitus and neonatal prognosis. | Ginekol Pol | 2023 | 35894480 | PubTator, text mining | PubMed |
| An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its Applications. | Mol Biotechnol | 2023 | 35474409 | PubTator, text mining | PubMed |
| Knockdown of Long Noncoding RNA Urothelial Carcinoma-Associated 1 Represses Gallbladder Cancer Advancement by Regulating SPOCK1 Expression Through Sponging miR-613. | Cancer Biother Radiopharm | 2023 | 33090888 | PubTator, text mining | PubMed |
| Retraction: Exosomal long non-coding RNA UCA1 functions as growth inhibitor in esophageal cancer. | Aging (Albany NY) | 2022 | 38232302 | PubTator, text mining | PubMed |
| Noncoding RNAs in apoptosis: identification and function. | Turk J Biol | 2022 | 37533667 | PubTator, text mining | PubMed |
| The tamoxifen-regulated, long non-coding RNA LINC00992 affects proliferation, migration, and expression of tamoxifen resistance-associated genes in MCF-7 breast cancer cells. | Contemp Oncol (Pozn) | 2022 | 36816389 | PubTator, text mining | PubMed |
| Screening potential lncRNA biomarkers for breast cancer and colorectal cancer combining random walk and logistic matrix factorization. | Front Genet | 2022 | 36744179 | PubTator, text mining | PubMed |
| Exosomes: A potential tool for immunotherapy of ovarian cancer. | Front Immunol | 2022 | 36741380 | PubTator, text mining | PubMed |
| Targeting lncRNAs of colorectal cancers with natural products. | Front Pharmacol | 2022 | 36699052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=27